glycerylphosphorylcholine has been researched along with Atherogenesis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buffa, J; Culley, MK; DiDonato, JA; Hazen, J; Hazen, SL; Jia, X; Krajcik, D; Levison, BS; Lusis, AJ; Nieuwdorp, M; Nimer, N; Org, E; Osborn, LJ; van den Born, BH; Wang, Z; Zhao, Y; Zwinderman, K | 1 |
| Breitbart, E; Feige, E; George, J; Hait-Darshan, R; Harats, D; Levi, I; Mendel, I; Polonsky, O; Propheta-Meiran, O; Salem, Y; Shoham, A; Yacov, N | 1 |
| Breitbart, E; Feige, E; George, J; Harats, D; Ishai, E; Levi, I; Mendel, I; Propheta-Meiran, O; Salem, Y; Shoham, A; Yacov, N | 1 |
| Feige, E; George, J; Harats, D; Mendel, I; Yacov, N | 1 |
| AIRO, R; MEARDI, G; TAVERNA, PL | 1 |
1 review(s) available for glycerylphosphorylcholine and Atherogenesis
| Article | Year |
|---|---|
Modified phospholipids as anti-inflammatory compounds.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Atherosclerosis; Dendritic Cells; Disease Models, Animal; Epigenesis, Genetic; Glycerylphosphorylcholine; Humans; Inflammation; Mice; Multiple Sclerosis; Oxidation-Reduction; Phospholipids; Psoriasis; Rabbits; Signal Transduction; Toll-Like Receptors | 2010 |
1 trial(s) available for glycerylphosphorylcholine and Atherogenesis
| Article | Year |
|---|---|
VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.
Topics: Animals; Atherosclerosis; Cholesterol; Glycerylphosphorylcholine; HEK293 Cells; Humans; Immunity, Innate; Lipopolysaccharide Receptors; Male; Mice; Monocytes; Rabbits; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2014 |
3 other study(ies) available for glycerylphosphorylcholine and Atherogenesis
| Article | Year |
|---|---|
The Nutritional Supplement
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cecum; Cell Line; Dietary Supplements; Endothelial Cells; Fatty Acids, Volatile; Feces; Female; Gastrointestinal Microbiome; Glycerylphosphorylcholine; Humans; Male; Methylamines; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S | 2021 |
Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemotaxis; Cholesterol; Disease Models, Animal; Female; Flow Cytometry; Glycerylphosphorylcholine; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Peritonitis; Receptors, Chemokine; Signal Transduction; Triglycerides; Vasculitis | 2013 |
[Activity of the alpha-glycerophosphorylcholine esters of essential fatty acids on the plasma lipoprotein picture after a fatty meal in normal subjects and in patients with atherosclerosis. I. Research on the turbidimetric curve after loading].
Topics: Arteriosclerosis; Atherosclerosis; Choline; Esters; Fatty Acids, Essential; Glycerophosphates; Glycerylphosphorylcholine; Humans; Lipoproteins; Phospholipids | 1960 |